author-photo

John Edward Norris Morten

AstraZeneca

11

Papers

312

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies

2015 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (35)
ATM deficiency as a potential therapeutic target for the PARP inhibitor olaparib in head and neck squamous cell carcinoma.

2011
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 5088: Exploring ATM deficiency as a potential therapeutic target for the PARP inhibitor olaparib in head and neck squamous cell carcinoma

2011 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Occurrence and pharmacological characterization of four human tachykinin NK2 receptor variants.

2008 Biochemical Pharmacology
Show All
- Source
- Cite
- Save
Citations (4)
A stop codon mutation in SCN9A causes lack of pain sensation.

2007 Human Molecular Genetics
Show All
- Source
- Cite
- Save
Citations (155)
Sequence variants in the melatonin-related receptor gene (GPR50) associate with circulating triglyceride and HDL levels

2006 Journal of Lipid Research
Show All
- Source
- Cite
- Save
Citations (36)
Characterization of a naturally-occurring polymorphism in the UHR-1 gene encoding the putative rat prolactin-releasing peptide receptor

2005 Peptides
Show All
- Source
- Cite
- Save
Citations (15)
Chromosome damage in G0 X-irradiated lymphocytes from patients with hereditary retinoblastoma.

1981 Cancer Research
Show All
- Source
- Cite
- Save
Citations (31)